/Investor DB

OS Fund — 2016 Investments

3 investments dated 2016 · listed companies and verified rows first · show all

Elysium Healthelysiumhealth.cominOct 2016

Elysium develops healthcare products focused on aging research and healthy aging rather than disease treatment.

HealthtechLongevityWellness & FitnessNew York City, US

Leonard Guarente, Ph.D.(Co-founder & Chief Scientist)Dan Alminana(COO, co-founder)inEric Marcotulli(CEO, co-founder)inJason AndersoninLeonard Guarente, PhD(Co-founder & Chief Scientist)David Fialkow(Director)

Co-investorsBreyer CapitalGaingelsSprint VcThe Venture CollectiveWestern Technology InvestmentGeneral Catalyst+2 more

Lygoslygos.comin𝕏Series A · Dec 2016 · $13M

Lygos was a performance materials company that used proprietary biology and chemistry to develop sustainable, high-performance ingredients and polymers.

BiotechCleantechClimate TechHealthtechNew MaterialsSan Francisco, US

Eric Steen(CEO)inJeffrey A. Dietrich(Executive Officer, Director)inJay D. Keasling(Director)Jeffrey Dietrich(CTO)in

BoardLeonard Katz(Director)

Co-investorsFifty YearsFundersClubJude GomilaLG Technology VenturesY Combinator10x Founders+10 more

uBiomeubiome.comMay 2016

San Francisco, US

Zachary Apte(Executive Officer, Director)Jessica Richman(Executive Officer, Director)

BoardJoseph Lonsdale(Director)Witt Wisebram(Director)

Co-investorsMilliways Ventures8VCDentsu VenturesSlow VenturesY Combinator

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.